-
Misonix Shares Soar on FDA Clearance at 2006-02-06 23:45:40
Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other health conditions, today announced that the Food and Drug Administration ("FDA") has granted 510(k) clearance for Misonix to market and sell the Sonatherm 600 Ultrasonic Lesion Generating System in the U.S. for ablation of certain soft tissue lesions in Gener Source - http://feeds.feedburner.com/AntSonsWordOntheStreet?m=404
|